Cohort Studymoderate evidence
Blood-based circular RNAs for early diagnosis of Alzheimer's disease.
Nature medicine·July 1, 2026·PMID 42387213
Why it mattersBlood circRNAs may offer a non-invasive, highly accurate tool for early AD detection and prognosis, potentially improving upon current plasma biomarkers like pTau217.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled